Published in Carbohydr Res on April 02, 1990
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother (1997) 5.76
Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun (1994) 3.46
Compounds active against cell walls of medically important fungi. Clin Microbiol Rev (1993) 2.67
A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell (2003) 2.59
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis (2011) 2.54
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother (1995) 2.37
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun (1991) 2.19
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect Immun (1991) 1.90
Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell (2007) 1.45
Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun (1995) 1.45
The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev (2012) 1.45
How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol (2009) 1.43
Galactoxylomannans of Cryptococcus neoformans. Infect Immun (1992) 1.42
Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans. Infect Immun (1992) 1.41
Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol Microbiol (2007) 1.38
Activation of the complement system by pathogenic fungi. Clin Microbiol Rev (1996) 1.37
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun (1995) 1.32
Role of the alpha-glucanase Agn1p in fission-yeast cell separation. Mol Biol Cell (2004) 1.31
Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect Immun (1994) 1.26
Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev (2004) 1.22
Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc Natl Acad Sci U S A (2009) 1.19
UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis. Eukaryot Cell (2004) 1.16
Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect Immun (1996) 1.16
Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect Immun (1993) 1.11
Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infect Immun (2000) 1.06
Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun (2009) 1.04
Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans. Eukaryot Cell (2006) 1.04
KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans. Mol Microbiol (2010) 1.01
Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryot Cell (2010) 0.98
Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect Immun (1997) 0.90
Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infect Immun (2011) 0.87
Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. Infect Immun (2004) 0.85
Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans. MBio (2014) 0.84
Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence (2010) 0.84
Properties of various Rho1 mutant alleles of Cryptococcus neoformans. J Bacteriol (2000) 0.81
Cryptococcus neoformans mediator protein Ssn8 negatively regulates diverse physiological processes and is required for virulence. PLoS One (2011) 0.80
Extracellular vesicles from Paracoccidioides pathogenic species transport polysaccharide and expose ligands for DC-SIGN receptors. Sci Rep (2015) 0.79
Characterization of Lipids and Proteins Associated to the Cell Wall of the Acapsular Mutant Cryptococcus neoformans Cap 67. J Eukaryot Microbiol (2015) 0.75
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science (2000) 5.84
Responses of Atriplex spongiosa and Suaeda monoica to Salinity. Plant Physiol (1979) 3.10
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol Immunol (1980) 2.98
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol (1995) 2.75
Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol (1998) 2.65
Genetic differences between type I and type II Candida stellatoidea. Infect Immun (1989) 2.38
Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast (1993) 2.26
Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis (1984) 2.22
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun (1998) 2.12
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun (1988) 2.11
Chromosome 22qII deletions. An under-recognised cause of idiopathic learning disability. Br J Psychiatry (1998) 2.03
Galactomannan antigenemia in invasive aspergillosis. Infect Immun (1979) 1.94
Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med (1972) 1.86
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res (1984) 1.79
Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay. J Infect Dis (1981) 1.77
Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls. Infect Immun (1974) 1.76
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res (1998) 1.72
Physiologic hyperparathyroidism in pregnancy. J Clin Endocrinol Metab (1972) 1.70
Caclium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med (1969) 1.66
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest (1971) 1.66
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. Infect Immun (1980) 1.65
Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida. Curr Microbiol (1998) 1.64
The relationship of 4-hydroxybenzoic acid to lysine and methionine formation in Escherichia coli. Biochem J (1967) 1.64
Partial characterization of the trait for enhanced K(+)-Na (+) discrimination in the D genome of wheat. Planta (1990) 1.63
Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes (1983) 1.61
Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun (1999) 1.60
Presence of Two Different Membrane-bound, KCl-stimulated Adenosine Triphosphatase Activities in Maize Roots. Plant Physiol (1975) 1.60
Regulation of lactating-rat mammary-gland lipogenesis by insulin and glucagon in vivo. The role and site of action of insulin in the transition to the starved state. Biochem J (1984) 1.59
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn Immunol (1984) 1.57
Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol (1977) 1.56
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun (1989) 1.55
Dissociation of mannan--serum complexes and detection of Candida albicans mannan by enzyme immunoassay variations. Clin Chem (1982) 1.54
Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol (1989) 1.52
Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun (1997) 1.52
The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest (1970) 1.50
Serum levels of penicillin in basic trainees in the U.S. Army who received intramuscular penicillin G benzathine. Clin Infect Dis (1996) 1.47
Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest (1973) 1.47
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med (2000) 1.46
X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science (1998) 1.46
Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity (2000) 1.44
Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med (1969) 1.44
Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians (1968) 1.44
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol (1997) 1.43
Short-term dietary regulation of lipogenesis in the lactating mammary gland of the rat. Adv Enzyme Regul (1983) 1.43
Galactoxylomannans of Cryptococcus neoformans. Infect Immun (1992) 1.42
Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin Microbiol (1985) 1.41
Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis. J Clin Microbiol (1984) 1.41
Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Carbohydr Res (1988) 1.41
Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence. J Clin Microbiol (1986) 1.40
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest (1973) 1.39
Circulating parathyroid hormone concentration in chronic renal insufficiency. Arch Intern Med (1969) 1.39
Regression curves for maternal serum inhibin A. Prenat Diagn (1999) 1.38
Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med (1974) 1.37
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy. Carbohydr Res (1992) 1.34
On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Kidney Int (1972) 1.34
Alcohol histories taken from elderly people on admission. BMJ (1994) 1.33
Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans. J Med Vet Mycol (1990) 1.32
Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Curr Top Med Mycol (1985) 1.30
Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest (1975) 1.30
Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients. Mycopathologia (1980) 1.30
Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol (1988) 1.29
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun (1997) 1.28
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun (1997) 1.27
An electrophoretic karyotype for Candida albicans reveals large chromosomes in multiples. Mol Gen Genet (1987) 1.26
Physiological significance of altered insulin metabolism in the conscious rat during lactation. Biochem J (1984) 1.25
Invasive aspergillosis: antiserum for circulating antigen produced after immunization with serum from infected rabbits. Infect Immun (1978) 1.25
Nucleotide sequence of the Candida albicans aspartyl proteinase gene. Nucleic Acids Res (1989) 1.23
Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels. J Clin Invest (1972) 1.22
Genesis of hyperparathyroidism. Am J Med (1971) 1.20
Capsular polysaccharides of Clostridium perfringens Hobbs 5. Biochemistry (1971) 1.20
An assessment of quaternary ammonium and related compounds as osmotic effectors in crop plants. Basic Life Sci (1979) 1.20
Alterations in mammary-gland blood flow and glucose metabolism in the lactating rat induced by short-term starvation and refeeding. Biosci Rep (1984) 1.19
Serial enzymatic hydrolysis of cell walls of two serotypes of yeast-form Histoplasma capsulatum with alpha(1 leads to 3)-glucanase, beta(1 leads to 3)-glucanase, pronase, and chitinase. Infect Immun (1977) 1.19
Ubiquinone deficiency in an auxotroph of Escherichia coli requiring 4-hydroxybenzoic acid. Biochem J (1967) 1.17
Heterogeneity of the purified extracellular aspartyl proteinase from Candida albicans: characterization with monoclonal antibodies and N-terminal amino acid sequence analysis. Infect Immun (1993) 1.17
Outcome of Autologous Matrix Induced Chondrogenesis (AMIC) in cartilage knee surgery: data of the AMIC Registry. Arch Orthop Trauma Surg (2012) 1.17
Composition of the capsular polysaccharides of Clostridium perfringens as a basis for their classification by chemotypes. Can J Microbiol (1975) 1.16
Monoclonal antibodies against isoelectrically focused Nocardia asteroides proteins characterized by the enzyme-linked immunoelectro-transfer blot method. Diagn Immunol (1986) 1.14
Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. J Clin Invest (1978) 1.14
Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med (1984) 1.13
The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen. Infect Immun (1992) 1.11
Evaluation of cation exchange chromatography for the isolation of M glycoprotein from histoplasmin. J Med Vet Mycol (1993) 1.10
Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun (2001) 1.08
Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron (1997) 1.08
Detection of Candida albicans mannan by immunodiffusion, counterimmunoelectrophoresis, and enzyme-linked immunoassay. Mycopathologia (1980) 1.07
Immunochemistry of the capsular polysaccharides from Clostridium perfringens: selected Hobbs strains 1, 5, 9, and 10. Infect Immun (1972) 1.07
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy. Carbohydr Res (1996) 1.07
Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infect Immun (2000) 1.06